Peking University People's Hospital北京大学人民医院
Xu Lanping
Hematology

Xu Lanping

许兰平

Chief Physician

Peking University People's Hospital北京大学人民医院· Beijing

Areas of Expertise

Hematopoietic stem cell transplantation (allo-HSCT)Severe aplastic anemia (SAA)Leukemia (AML, ALL, CML)Lymphoma and multiple myelomaGraft-versus-host disease (GvHD)Post-transplant lymphoproliferative disorders and transplant-related infectious complications

Professional Biography

Dr. Xu Lanping is Chief Physician in Hematology at Peking University People's Hospital, Beijing. Xu serves as Vice Director. Clinical expertise includes Hematopoietic stem cell transplantation (allo-HSCT) — haploidentical, matched-sibling, and mismatched-unrelated donor, Severe aplastic anemia (SAA) — haploidentical HSCT and immunosuppressive therapy, Leukemia (AML, ALL, CML) — transplant and non-transplant management, Lymphoma and multiple myeloma. Core member of the 'Beijing Protocol' for haploidentical (HLA-mismatched) HSCT — one of three globally recognized haploidentical transplant protocols; Peking University People's Hospital has performed more haploidentical HSCTs than any other single centre worldwide. National Science and Technology Progress Award (Second Class) — twice (2014 and 2017) — as a core member of Huang Xiaojun's haploidentical HSCT research group, one of China's most decorated transplant teams.

International Patient Services

Full support for your journey to China

Request Consultation

Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.

English Consultations

Full English-speaking medical appointments

Medical Translation

Dedicated translation for all documentation

Visa Assistance

Medical visa application support